Soft Tissue Repair Global Market Report 2024

Soft tissue repair involves the replacement of wounded or damaged tissues with healthy tissues, and the soft tissue repair market is responsible for manufacturing products designed for this purpose.

The main types of soft tissue repair products include fixation devices, tissue patches or meshes, and laparoscopic instruments. Fixation devices are utilized to provide alignment and stabilization to torn connective tissue. Examples include cortical buttons and corresponding suture kits, enabling tension and the ability to attach tendons or tendon grafts directly to bones inside pre-drilled sockets. Tissue patches or meshes are specialty biomaterials used for supporting damaged tissues during the healing process. Laparoscopic instruments comprise various tools like dissectors, graspers, scissors, electrodes, needle holders, and shaft and connection configurations for handling soft tissues during surgeries. Soft tissue repair finds applications in various medical procedures, including hernia repair, dural repair, skin repair, vaginal sling procedures, orthopedic repair, dental repair, and breast reconstruction. These products are used by hospitals, clinics, research and academic institutes, and other medical facilities.

The soft tissue repair market research report is one of a series of new reports that provides soft tissue repair market statistics, including soft tissue repair industry, global soft tissue repair market size, regional shares, competitors with a soft tissue repair market share, detailed soft tissue repair market segments, market trends and opportunities, and any further data you may need to thrive in the soft tissue repair industry. This soft tissue repair market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The soft tissue repair market size has grown strongly in recent years. It will grow from $11.66 billion in 2023 to $12.66 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth observed during the historical period can be attributed to several factors, including an increased prevalence of sports injuries, a growing aging population with associated degenerative diseases, an increase in healthcare expenditure, improved access to healthcare, and an elevated awareness and demand for cosmetic procedures.

The soft tissue repair market size is expected to see strong growth in the next few years. It will grow to $16.21 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The anticipated growth in the forecast period can be attributed to several factors, including an emphasis on patient education and rehabilitation, the expanding geriatric population with associated chronic diseases, the emergence of regenerative medicine and tissue engineering, a rise in healthcare expenditure, and the expanding trend of medical tourism. Additionally, a focus on prevention and early intervention in healthcare is expected to contribute to the growth of the soft tissue repair market. Major trends expected in the forecast period include the digitalization of healthcare and the integration of artificial intelligence (AI) for improved diagnostics and treatment planning. Collaborations and partnerships among healthcare entities are anticipated to drive innovation and efficiency. The use of customized and 3D-printed implants is expected to become more prevalent, and robot-assisted surgery is likely to enhance surgical precision. Wearable

The soft tissue repair market witnessed growth in the historic period due to the increasing cases of sports-related injuries. Sports injuries, occurring during sports or exercise, often involve soft tissues. Soft tissue injuries affect structures surrounding body organs and are prevalent in sports. According to the National Safety Council, exercise equipment accounted for the highest number of injuries in 2021, totaling around 409,000, with bicycles and accessories ranking second, causing 375,797 injuries in the US. Consequently, the rise in sport-related injuries significantly contributed to the expansion of the soft tissue repair market.

Anticipated growth in the number of aesthetic procedures is poised to drive the soft tissue repair market in the upcoming years. Aesthetic treatments encompass non-invasive to minimally invasive procedures aimed at enhancing a patient's physical appearance. Soft tissue repair plays a crucial role in achieving aesthetic improvements through surgical techniques and materials, aiding cosmetic and reconstruction surgeons. In 2022, plastic surgeons performed over 14.9 million surgical and 18.8 million non-surgical procedures, marking an 11.2% overall increase, according to a survey by the International Society of Aesthetic Plastic Surgery. This surge in aesthetic procedures is a key factor propelling the soft tissue repair market.

Strategic partnerships are a focal point for major companies in the soft tissue repair market to broaden their product portfolios. This collaborative approach involves companies leveraging each other's strengths and resources for mutual benefits. In August 2023, 3D Systems, a comprehensive provider of 3D printing products and services, joined forces with Theradaptive to advance orthopedic and soft tissue repair using regenerative therapeutics. Through this partnership, 3D Systems' 3D printed medical devices will incorporate Theradaptive's protein-based material-binding variations to promote bone and tissue development. Theradaptive, a biopharmaceutical company, specializes in developing therapies for restoring the quality of life.

Investment in technological advancements is a strategic focus for companies in the soft tissue repair market to enhance market share and offer innovative products. In May 2022, Paragon 28 Inc. launched the Grappler Suture Anchor System, addressing challenges in soft tissue adjustment and ligament regeneration during acute foot and ankle surgeries. This system includes PEEK and titanium anchors, designed for efficiency in the operating room, and aims to simplify the repair process. Companies like Paragon 28 Inc. are driving innovation in soft tissue repair through advanced technological solutions.

In July 2021, Becton, Dickinson, and Company (BD) acquired Tepha, Inc., a move aimed at strengthening BD's surgical mesh category. This acquisition enhances BD's capacity for soft tissue repair and regeneration advancements, particularly in resorbable mesh technology. BD's commitment to offering innovative solutions to clinicians and patients is a key aspect of the strategic acquisition. Tepha Inc., specializing in the development of surgical meshes for soft tissue repair and regeneration, aligns with BD's mission to advance healthcare solutions.

Major companies operating in the soft tissue repair market include Organogenesis Inc., Stryker Corporation, Johnson & Johnson Pvt. Ltd., Arthrex Inc., CryoLife Inc., Integra Lifesciences Corporation., Wright Medical Technology Inc., Smith & Nephew plc., C.R. Bard Inc., Medtronic PLC., Zimmer Biomet Holdings Inc., Lifenet Health Inc., Isto Biologics Company Inc., Covidien plc., Becton Dickinson and Company, LifeCell Corporation, Baxter Healthcare Corporation., Boston Scientific Corporation, Acelity L.P. Inc., Artivion Inc., Medprin Biotech GmbH., Medline Industries Inc., Cook Group Inc., Ethicon US LLC, RTI Surgical Inc., Tornier Inc., Atrium Medical Corporation., Coloplast Corp., ConvaTec Group PLC, Endo International PLC, Kinetic Concepts Inc., Mölnlycke Health Care AB

North America was the largest region in the soft tissue repair market in 2023. Asia-Pacific region is predicted to record fastest growth over the forecast period. The regions covered in the soft tissue repair market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the Soft Tissue Repair market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The soft tissue repair market includes revenues earned by entities by tissue engineering, regeneration and tissue adhesive. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.